Mathijssen H - Search Results

1

Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.

Vis R, Mathijssen H, Keijsers RGM, van de Garde EMW, Veltkamp M, Akdim F, Post MC, Grutters JC. Vis R, et al. Among authors: mathijssen h. J Nucl Cardiol. 2023 Aug;30(4):1543-1553. doi: 10.1007/s12350-022-03171-6. Epub 2023 Jan 14. J Nucl Cardiol. 2023. PMID: 36640249

2

Sarcoidosis-Associated Pulmonary Hypertension.

Huitema MP, Mathijssen H, Mager JJ, Snijder RJ, Grutters JC, Post MC. Huitema MP, et al. Among authors: mathijssen h. Semin Respir Crit Care Med. 2020 Oct;41(5):659-672. doi: 10.1055/s-0040-1713615. Epub 2020 Aug 10. Semin Respir Crit Care Med. 2020. PMID: 32777851 Review.

3

Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series.

Mathijssen H, Huitema MP, Bakker ALM, Mager JJ, Snijder RJ, Grutters JC, Post MC. Mathijssen H, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(1):74-78. doi: 10.36141/svdld.v37i1.9292. Epub 2020 Mar 15. Sarcoidosis Vasc Diffuse Lung Dis. 2020. PMID: 33093771 Free PMC article.

4

Effectiveness and safety of infliximab in cardiac Sarcoidosis.

Bakker ALM, Mathijssen H, Azzahhafi J, Swaans MJ, Veltkamp M, Keijsers RGM, Akdim F, Post MC, Grutters JC. Bakker ALM, et al. Among authors: mathijssen h. Int J Cardiol. 2021 May 1;330:179-185. doi: 10.1016/j.ijcard.2021.02.022. Epub 2021 Feb 12. Int J Cardiol. 2021. PMID: 33582196

5

Clinical Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension.

Mathijssen H, Huitema MP, Bakker ALM, Smits F, Mager JJ, Snijder RJ, Grutters JC, Post MC. Mathijssen H, et al. Heart Lung Circ. 2021 Oct;30(10):1502-1508. doi: 10.1016/j.hlc.2021.03.279. Epub 2021 Apr 28. Heart Lung Circ. 2021. PMID: 33933365

6

Value of echocardiography using knowledge-based reconstruction in determining right ventricular volumes in pulmonary sarcoidosis: comparison with cardiac magnetic resonance imaging.

Mathijssen H, Huitema MP, Bakker ALM, Akdim F, van Es HW, Grutters JC, Post MC. Mathijssen H, et al. Int J Cardiovasc Imaging. 2022 Feb;38(2):309-316. doi: 10.1007/s10554-021-02405-x. Epub 2021 Sep 29. Int J Cardiovasc Imaging. 2022. PMID: 34586530

7

Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis.

Bakker A, Mathijssen H, Dorland G, Balt JC, van Dijk VF, Veltkamp M, Akdim F, Grutters JC, Post MC. Bakker A, et al. Among authors: mathijssen h. Heart Rhythm. 2022 Mar;19(3):352-360. doi: 10.1016/j.hrthm.2021.11.025. Epub 2021 Nov 26. Heart Rhythm. 2022. PMID: 34843965

8

The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis.

Mathijssen H, Tjoeng TWH, Keijsers RGM, Bakker ALM, Akdim F, van Es HW, van Beek FT, Veltkamp MV, Grutters JC, Post MC. Mathijssen H, et al. EJNMMI Res. 2021 Dec 20;11(1):129. doi: 10.1186/s13550-021-00870-y. EJNMMI Res. 2021. PMID: 34928457 Free PMC article.

9

Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screening.

Huitema MP, Mathijssen H, Bakker ALM, Mager JJ, van Houten L, Grutters JC, Post MC. Huitema MP, et al. Among authors: mathijssen h. Respir Med. 2022 Apr-May;195:106762. doi: 10.1016/j.rmed.2022.106762. Epub 2022 Feb 20. Respir Med. 2022. PMID: 35227546 Free article.

10

Predictors of appropriate implantable cardiac defibrillator therapy in cardiac sarcoidosis.

Mathijssen H, Bakker ALM, Balt JC, Akdim F, van Es HW, Veltkamp M, Grutters JC, Post MC. Mathijssen H, et al. J Cardiovasc Electrophysiol. 2022 Jun;33(6):1272-1280. doi: 10.1111/jce.15484. Epub 2022 Apr 15. J Cardiovasc Electrophysiol. 2022. PMID: 35411644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page